首页> 外文期刊>Therapeutic apheresis and dialysis: official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy >Elevated D-Dimer Level is a Risk Factor for Coronary Artery Lesions Accompanying Intravenous Immunoglobulin-Unresponsive Kawasaki Disease
【24h】

Elevated D-Dimer Level is a Risk Factor for Coronary Artery Lesions Accompanying Intravenous Immunoglobulin-Unresponsive Kawasaki Disease

机译:D-二聚体水平升高是伴随免疫球蛋白无反应的川崎病伴发冠状动脉病变的危险因素

获取原文
获取原文并翻译 | 示例
           

摘要

Although there are many reports on the resistance of Kawasaki disease (KD) to initial intravenous immunoglobulin (IVIg) therapy, risk factors for coronary artery lesions in such cases remain to be established. The objective of this study was to explore when additional therapies should be administered and to identify factors helpful for selecting a therapeutic option. Based on their written clinical records, we performed a retrospective review of KD patients who did not respond to initial IVIg therapy and who therefore then underwent plasma exchange (PE) therapy. This was a case-control study to compare the presence or absence of acute coronary lesions in patients treated by PE for IVIg-unresponsive KD at Yokohama City University Hospital or at Yokohama City University Medical Center. Fifteen of 44 patients had acute coronary artery lesions (CAL) correlating with high levels of white blood cells (WBC) (P = 0.045), d-dimer (P = 0.008), and fibrin/fibrinogen degradation products (P = 0.009) and lower levels of fibrinogen (P = 0.013) prior to PE therapy. There was a strong correlation between pre-PE levels of albumin and d-dimer (Pearson's correlation coefficient of 0.610). Multivariate analyses revealed that the odds ratio for CAL when d-dimer was 4.5g/mL was 25.06 (95% CI, 2.56-244.91, P = 0.006). d-dimer elevation and albumin decline in IVIg-unresponsive KD patients could be risk factors for acute CAL, suggesting the possibility that angitis has spread throughout the arterial system, as far as the coronary artery.
机译:尽管有许多关于川崎病(KD)对初始静脉免疫球蛋白(IVIg)治疗具有抗药性的报道,但在这种情况下冠状动脉病变的危险因素仍有待确定。这项研究的目的是探讨何时应进行其他治疗,并确定有助于选择治疗选择的因素。基于他们的书面临床记录,我们对未对初始IVIg治疗产生反应并因此接受血浆置换(PE)治疗的KD患者进行了回顾性研究。这项病例对照研究比较了横滨市立大学医院或横滨市立大学医学中心接受PE治疗IVIg无反应性KD的患者是否存在急性冠状动脉病变。 44例患者中有15例患有急性冠状动脉病变(CAL),与高水平的白细胞(WBC)(P = 0.045),d-二聚体(P = 0.008)和纤维蛋白/纤维蛋白原降解产物(P = 0.009)相关, PE治疗前血纤维蛋白原水平较低(P = 0.013)。 PE之前的白蛋白水平与d-二聚体之间有很强的相关性(Pearson相关系数为0.610)。多变量分析显示,当d-二聚体为4.5 g / mL时,CAL的优势比为25.06(95%CI,2.56-244.91,P = 0.006)。 IVIg无反应的KD患者中d-二聚体升高和白蛋白下降可能是急性CAL的危险因素,这表明血管炎可能扩散到整个动脉系统,甚至冠状动脉。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号